$1.58 -0.12 (%) Anthera Pharmaceuticals Inc - NASDAQ

Dec. 19, 2014 | 04:00 PM

Partner Headlines

  1. Anthera Pharmaceuticals Announces Update On Strategic Partnership Discussions for Blisibimod

    Benzinga | Oct. 1, 2014 | 16:00PM EST
  2. Stocks Hitting 52-Week Lows

    Benzinga | Sep. 17, 2014 | 10:07AM EST
  3. Benzinga's Top #PreMarket Gainers

    Benzinga | Jul. 15, 2014 | 08:14AM EST
  4. Anthera Pharmaceuticals Announces Acquisition of Sollpura For Exocrine Pancreatic Insufficiency From Eli Lilly And Company - No Terms

    Benzinga | Jul. 14, 2014 | 16:43PM EST
  5. Hansen Medical Announces Appointment of Chris Lowe as Interim CEO; Bruce Barclay to Depart the Company

    Benzinga | Feb. 10, 2014 | 16:16PM EST
  6. Anthera Pharmaceuticals Accused of Withholding Data

    Benzinga | Nov. 20, 2013 | 15:16PM EST
  7. Anthera Pharmaceuticals Inc. Reports Operating Results (10-Q)

    GuruFocus | Nov. 8, 2012 | 11:36AM EST
  8. Benzinga's Microcap Movers for Monday September 17, 2012

    Benzinga | Sep. 17, 2012 | 16:29PM EST
  9. Benzinga's Microcap Movers for Friday August 24, 2012

    Benzinga | Aug. 26, 2012 | 03:27AM EST
  10. Anthera Pharmaceuticals Inc. Reports Operating Results (10-Q)

    GuruFocus | Aug. 9, 2012 | 06:33AM EST
  11. Anthera Pharmaceuticals Announces Pricing of Public Offering of Common Stock; 33M Shares at $1.00/Share

    Benzinga | Jul. 19, 2012 | 03:16AM EST
  12. Benzinga's Microcap Movers for Wednesday July 18, 2012

    Benzinga | Jul. 18, 2012 | 16:00PM EST
  13. Anthera Pharmaceuticals Announces Proposed Public Offering of Common Stock; No Amount Given

    Benzinga | Jul. 18, 2012 | 10:23AM EST
  14. Benzinga's Microcap Movers for Tuesday July 17, 2012

    Benzinga | Jul. 17, 2012 | 10:57AM EST
  15. Benzinga's Microcap Movers for Monday July 16, 2012

    Benzinga | Jul. 16, 2012 | 10:38AM EST
  16. Anthera Pharmaceuticals Provides Additional Data from the Recently Completed PEARL-SC Study of Blisibimod in the Proposed Phase 3 Population

    Benzinga | Jul. 16, 2012 | 02:45AM EST
  17. Anthera Pharmaceuticals Inc. (ANTH) CEO Paul F Truex buys 20,000 Shares

    GuruFocus | Jul. 2, 2012 | 12:19PM EST
  18. ProShares Trust Ultra VIX Short Term Futures ETF, Nokia Corporation Among Stocks setting 52-Week Lows Friday

    FoxBusiness | Jun. 29, 2012 | 06:32AM EST
  19. Health Care Sector Wrap

    FoxBusiness | Jun. 28, 2012 | 10:47AM EST
  20. Anthera Pharmaceuticals Down 65% After Reporting Phase 2b PEARL-SC Clinical Study Results

    Benzinga | Jun. 28, 2012 | 04:55AM EST
  21. Benzinga's Top Downgrades

    Benzinga | Jun. 28, 2012 | 01:40AM EST
  22. Anthera Updates Phase 3 Plans

    Benzinga | Jun. 27, 2012 | 11:57AM EST
  23. Benzinga's Microcap Movers for Friday June 15, 2012

    Benzinga | Jun. 16, 2012 | 04:01AM EST
  24. Stock Futures Little Changed Ahead of Data with Morgan Stanley (MS) and Google (GOOG) on the Move

    MarketIntelligenceCenter | Mar. 16, 2012 | 08:03AM EST
  25. UPDATE: Summer Street Research Partners Initiates Buy, $15 PT on Anthera Pharmaceuticals

    Benzinga | Mar. 2, 2012 | 06:19AM EST
  26. Morning Social Media Outlook for Wednesday Feb 22

    Benzinga | Feb. 22, 2012 | 04:05AM EST
  27. Anthera Pharmaceuticals Inc. (ANTH) President and CEO Paul F Truex sells 15,000 Shares

    GuruFocus | Dec. 16, 2011 | 15:31PM EST
  28. Anthera Announces Completion of Safety Review by DSMB for VISTA-16

    Benzinga | Dec. 14, 2011 | 10:00AM EST
  29. UPDATE: Canaccord Initiates Buy, $13 Target on Anthera Pharmaceuticals

    Benzinga | Dec. 8, 2011 | 02:37AM EST
  30. Canaccord Initiates Anthera Pharmaceuticals at Buy, $13 PT

    Benzinga | Dec. 8, 2011 | 01:17AM EST
Trading Center